Deputy: I understand your frustration, but I still

Deputy: I understand your frustration, but I still have hope, not so much for December but for Q1 2015. We probably will get the ICON validation testing in the coming days, and possibly the LP002 Lympro data before year end. That's the launch! LOL. If the numbers are decent the pps may rise a bit. But what I am holding out hope for is a PR telling us of a Pharma that has committed to use Lympro in their AD clinical trial. I think that alone will get us over .10 cents and give the stock price momentum. I hope we get that news before year end, but if not, I can't imagine not hearing of 1 or 2 or 3 pharma's signing up with us in January. That will be the news the market is waiting for, assuring them that Lympro is being accepted by the Alzheimer's world.

With the news of Lympro starting to be accepted....everything else will fall in place. The market will then be much more willing to be excited about the RP orphan, and the Eltoprazine IND and start up of phase 2b, as well as ESS.

All I want for Christmas is news of a Phama willing to use Lympro. Is that asking too much? I think not. I'd even be willing to get my Christmas present a week or two late. But no later than that.